[go: up one dir, main page]

SI1010699T1 - 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives - Google Patents

5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives

Info

Publication number
SI1010699T1
SI1010699T1 SI9830774T SI9830774T SI1010699T1 SI 1010699 T1 SI1010699 T1 SI 1010699T1 SI 9830774 T SI9830774 T SI 9830774T SI 9830774 T SI9830774 T SI 9830774T SI 1010699 T1 SI1010699 T1 SI 1010699T1
Authority
SI
Slovenia
Prior art keywords
naphthyridin
oxadiazolyl
derivatives
substituted
Prior art date
Application number
SI9830774T
Other languages
English (en)
Slovenian (sl)
Inventor
Kazunori Ohno
Osamu Odai
Kaoru Masumoto
Kiyoshi Furukawa
Makoto Oka
Original Assignee
Dainippon Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co., Ltd. filed Critical Dainippon Pharmaceutical Co., Ltd.
Publication of SI1010699T1 publication Critical patent/SI1010699T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9830774T 1997-07-15 1998-07-14 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives SI1010699T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20717997 1997-07-15
EP98931076A EP1010699B1 (en) 1997-07-15 1998-07-14 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives
PCT/JP1998/003134 WO1999003857A1 (en) 1997-07-15 1998-07-14 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives

Publications (1)

Publication Number Publication Date
SI1010699T1 true SI1010699T1 (en) 2005-10-31

Family

ID=16535559

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830774T SI1010699T1 (en) 1997-07-15 1998-07-14 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives

Country Status (28)

Country Link
US (2) US6172079B1 (ru)
EP (1) EP1010699B1 (ru)
JP (1) JP3390453B2 (ru)
KR (1) KR100508392B1 (ru)
CN (1) CN1134437C (ru)
AR (1) AR013222A1 (ru)
AT (1) ATE297923T1 (ru)
AU (1) AU735960B2 (ru)
BR (1) BR9811474B1 (ru)
CA (1) CA2296427C (ru)
DE (1) DE69830595T2 (ru)
DK (1) DK1010699T3 (ru)
EE (1) EE04372B1 (ru)
ES (1) ES2244065T3 (ru)
HU (1) HUP0004671A3 (ru)
ID (1) ID24047A (ru)
IL (2) IL133512A0 (ru)
NO (1) NO314999B1 (ru)
NZ (1) NZ501814A (ru)
PL (1) PL191200B1 (ru)
PT (1) PT1010699E (ru)
RU (1) RU2188199C2 (ru)
SI (1) SI1010699T1 (ru)
SK (1) SK285913B6 (ru)
TR (1) TR200000103T2 (ru)
TW (1) TW486479B (ru)
WO (1) WO1999003857A1 (ru)
ZA (1) ZA985870B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI298068B (en) * 2000-06-21 2008-06-21 Dainippon Sumitomo Pharma Co Pharmaceutical composition for schizophrenia
TW200533371A (en) * 2004-04-15 2005-10-16 Dainippon Pharmaceutical Co Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
US20100093875A1 (en) 2006-10-25 2010-04-15 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
WO2009105712A1 (en) * 2008-02-22 2009-08-27 Irm Llc Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
WO2010002451A1 (en) * 2008-07-01 2010-01-07 Concert Pharmaceuticals, Inc. Naphthyridin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415580A (en) 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones
US4567186A (en) * 1985-01-14 1986-01-28 Sterling Drug Inc. 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
IL101860A0 (en) * 1991-05-31 1992-12-30 Ici Plc Heterocyclic derivatives
AU664912B2 (en) * 1992-09-02 1995-12-07 Dainippon Pharmaceutical Co. Ltd. Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
JP2002241379A (ja) * 1997-03-21 2002-08-28 Dainippon Pharmaceut Co Ltd ３−オキサジアゾリルキノキサリン誘導体

Also Published As

Publication number Publication date
EE04372B1 (et) 2004-10-15
HK1028895A1 (en) 2001-03-09
CA2296427A1 (en) 1999-01-28
PL191200B1 (pl) 2006-03-31
BR9811474A (pt) 2000-08-15
CN1264380A (zh) 2000-08-23
US6277993B1 (en) 2001-08-21
US6172079B1 (en) 2001-01-09
SK285913B6 (sk) 2007-11-02
AR013222A1 (es) 2000-12-13
KR100508392B1 (ko) 2005-08-17
IL133512A (en) 2007-06-17
EP1010699A1 (en) 2000-06-21
AU8129498A (en) 1999-02-10
CA2296427C (en) 2006-11-14
NO314999B1 (no) 2003-06-23
RU2188199C2 (ru) 2002-08-27
KR20010021824A (ko) 2001-03-15
ATE297923T1 (de) 2005-07-15
CN1134437C (zh) 2004-01-14
JP3390453B2 (ja) 2003-03-24
WO1999003857A1 (en) 1999-01-28
DE69830595T2 (de) 2006-05-11
BR9811474B1 (pt) 2009-05-05
DK1010699T3 (da) 2005-10-10
PL338085A1 (en) 2000-09-25
ZA985870B (en) 1999-01-27
IL133512A0 (en) 2001-04-30
EP1010699A4 (en) 2001-09-12
NO20000183L (no) 2000-03-07
EP1010699B1 (en) 2005-06-15
TR200000103T2 (tr) 2000-06-21
EE200000029A (et) 2000-10-16
PT1010699E (pt) 2005-08-31
ID24047A (id) 2000-07-06
ES2244065T3 (es) 2005-12-01
HUP0004671A3 (en) 2001-12-28
AU735960B2 (en) 2001-07-19
DE69830595D1 (de) 2005-07-21
SK532000A3 (en) 2000-09-12
NZ501814A (en) 2002-02-01
NO20000183D0 (no) 2000-01-14
HUP0004671A2 (hu) 2001-05-28
TW486479B (en) 2002-05-11

Similar Documents

Publication Publication Date Title
ZA982853B (en) Nicotinamide derivatives.
IL125358A0 (en) 5H-thiazolo [3,2-a] pyrimidine derivatives
CZ20011556A3 (cs) Pyrazolopyridinové deriváty
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
IL133904A0 (en) Pyridine derivatives
DE69904602D1 (en) Substituierte 1,8-naphthyridin-4(1h)-one als phosphodiesterase 4-inhibitoren
ZA200203581B (en) Bicyclic imidazo-3-yl-amine derivatives.
IL149026A0 (en) PYRAZOLO [4, 3-d] PYRIMIDINE DERIVATIVES
ZA979593B (en) Naphthyridine derivatives.
PL354600A1 (en) Naphthyridine derivatives
SI0921125T1 (en) 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
IL127399A0 (en) 1,3,8-Triaza-spiro (4,5) decan-4-on derivatives
IL130377A0 (en) Diaza-spiro¬3,5¾nonane derivatives
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
IL133512A0 (en) 5-substituted -3- oxadiazolyl - 1, 6-naphthyridin - 2 (1h) - one derivatives
ZA985559B (en) Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives
IL155380A0 (en) SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
GB2323842A8 (en) Pyridine derivatives
ZA200203582B (en) Bicyclic imidazo-5-yl-amine derivatives.
PL325356A1 (en) Novel derivative 2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-5-carboxylic pyrolydinamide
EP0954316A4 (en) PYRIMIDINE DERIVATIVES
GB9608592D0 (en) Imidazopyridine derivatives
ZA986137B (en) Pyridine derivatives
ZA978806B (en) Indole-2,3-dione-3-oxime derivatives